| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |